We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
Cap. Flow
+$831M
Cap. Flow %
11.61%
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$146M
2
GILD icon
Gilead Sciences
GILD
+$116M
3
AMZN icon
Amazon
AMZN
+$86.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$84.7M
5
ADI icon
Analog Devices
ADI
+$80M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$73.2M
2
PANW icon
Palo Alto Networks
PANW
+$59.8M
3
ALKS icon
Alkermes
ALKS
+$55.3M
4
ACN icon
Accenture
ACN
+$53.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.05%
2 Technology 29.2%
3 Financials 8.76%
4 Industrials 7.7%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMIH
351
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
$3.61M 0.05%
367,600
– –
GTPB
352
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$3.61M 0.05%
367,500
+67,500
+23% +$663K
VERA icon
353
Vera Therapeutics
VERA
$2.3B
$3.61M 0.05%
+169,277
New +$3.17M
FATE icon
354
Fate Therapeutics
FATE
$290M
$3.6M 0.05%
160,718
– –
AAC
355
DELISTED
Ares Acquisition Corporation
AAC
$3.59M 0.05%
361,666
+75,000
+26% +$741K
BBY icon
356
Best Buy
BBY
$16.9B
$3.55M 0.05%
56,042
-5,935
-10% -$440K
EL icon
357
Estee Lauder
EL
$30.9B
$3.53M 0.05%
16,365
-13,416
-45% -$3.43M
ACQR
358
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$3.51M 0.05%
354,167
+154,167
+77% +$1.52M
SGHL
359
DELISTED
Signal Hill Acquisition Corp. Class A Common Stock
SGHL
$3.48M 0.05%
350,000
– –
FRON
360
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$3.47M 0.05%
350,000
– –
ZLS
361
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$3.46M 0.05%
354,215
– –
GTHX
362
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3.46M 0.05%
276,900
-1,520,282
-85% -$17.4M
PEGR
363
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$3.44M 0.05%
350,000
+50,000
+17% +$491K
ACCD
364
DELISTED
Accolade Inc
ACCD
$3.41M 0.05%
+298,766
New +$3.26M
PDCO
365
DELISTED
Patterson Companies, Inc.
PDCO
$3.39M 0.05%
141,220
-101,830
-42% -$2.91M
HRTX icon
366
Heron Therapeutics
HRTX
$94.5M
$3.37M 0.05%
797,906
-20,256
-2% -$79.3K
RBLX icon
367
Roblox
RBLX
$25.7B
$3.36M 0.05%
+93,709
New +$3.88M
LQDA icon
368
Liquidia Corp
LQDA
$7.95B
$3.33M 0.05%
+612,058
New +$3.43M
KRTX
369
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.28M 0.05%
14,585
-132,150
-90% -$26.7M
DISH
370
DELISTED
DISH Network Corp.
DISH
$3.27M 0.05%
236,469
-159,952
-40% -$2.83M
TRTL
371
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$3.25M 0.05%
+331,500
New +$3.23M
DGX icon
372
Quest Diagnostics
DGX
$26.3B
$3.24M 0.05%
26,408
-29,425
-53% -$3.88M
FSNB
373
DELISTED
Fusion Acquisition Corp. II
FSNB
$3.19M 0.04%
324,992
– –
EOCW
374
DELISTED
Elliott Opportunity II Corp.
EOCW
$3.19M 0.04%
324,000
+150,000
+86% +$1.47M
AFAQ
375
DELISTED
AF Acquisition Corp
AFAQ
$3.18M 0.04%
325,077
+75,077
+30% +$736K
13 14
15
16 17

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.

  • Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
  • Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
  • Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
  • Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
  • Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
  • Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
  • Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.